nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLCO4C1—Methotrexate—urinary bladder cancer	0.143	0.227	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—urinary bladder cancer	0.1	0.16	CbGbCtD
Liotrix—ABCB1—Mitomycin—urinary bladder cancer	0.0688	0.109	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—urinary bladder cancer	0.056	0.0891	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—urinary bladder cancer	0.0346	0.055	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—urinary bladder cancer	0.0326	0.0519	CbGbCtD
Liotrix—ALB—Fluorouracil—urinary bladder cancer	0.0324	0.0515	CbGbCtD
Liotrix—SLC22A8—Methotrexate—urinary bladder cancer	0.0301	0.0479	CbGbCtD
Liotrix—CYP2C8—Fluorouracil—urinary bladder cancer	0.025	0.0398	CbGbCtD
Liotrix—CYP2C8—Etoposide—urinary bladder cancer	0.0209	0.0332	CbGbCtD
Liotrix—ABCB1—Gemcitabine—urinary bladder cancer	0.0198	0.0315	CbGbCtD
Liotrix—ALB—Methotrexate—urinary bladder cancer	0.0179	0.0284	CbGbCtD
Liotrix—ABCB1—Cisplatin—urinary bladder cancer	0.0144	0.0229	CbGbCtD
Liotrix—ABCB1—Etoposide—urinary bladder cancer	0.0141	0.0225	CbGbCtD
Liotrix—ABCB1—Doxorubicin—urinary bladder cancer	0.00964	0.0153	CbGbCtD
Liotrix—ABCB1—Methotrexate—urinary bladder cancer	0.00934	0.0149	CbGbCtD
Liotrix—TTR—urine—urinary bladder cancer	0.00828	0.0782	CbGeAlD
Liotrix—SLC22A8—urine—urinary bladder cancer	0.00507	0.0479	CbGeAlD
Liotrix—THRB—prostate gland—urinary bladder cancer	0.004	0.0378	CbGeAlD
Liotrix—THRA—prostate gland—urinary bladder cancer	0.004	0.0378	CbGeAlD
Liotrix—SLC16A2—prostate gland—urinary bladder cancer	0.00362	0.0342	CbGeAlD
Liotrix—SLC10A1—prostate gland—urinary bladder cancer	0.00354	0.0334	CbGeAlD
Liotrix—SLCO4C1—seminal vesicle—urinary bladder cancer	0.00353	0.0333	CbGeAlD
Liotrix—SLC10A1—seminal vesicle—urinary bladder cancer	0.00299	0.0283	CbGeAlD
Liotrix—SLCO4C1—renal system—urinary bladder cancer	0.00284	0.0269	CbGeAlD
Liotrix—THRB—renal system—urinary bladder cancer	0.00273	0.0257	CbGeAlD
Liotrix—THRA—renal system—urinary bladder cancer	0.00273	0.0257	CbGeAlD
Liotrix—SLCO4A1—prostate gland—urinary bladder cancer	0.00266	0.0252	CbGeAlD
Liotrix—SLC16A2—urethra—urinary bladder cancer	0.00243	0.0229	CbGeAlD
Liotrix—SLC10A1—renal system—urinary bladder cancer	0.00241	0.0228	CbGeAlD
Liotrix—SLC16A10—prostate gland—urinary bladder cancer	0.00234	0.0221	CbGeAlD
Liotrix—SLCO1C1—renal system—urinary bladder cancer	0.00227	0.0214	CbGeAlD
Liotrix—SLCO4A1—seminal vesicle—urinary bladder cancer	0.00225	0.0213	CbGeAlD
Liotrix—THRA—female reproductive system—urinary bladder cancer	0.00218	0.0206	CbGeAlD
Liotrix—THRB—female reproductive system—urinary bladder cancer	0.00218	0.0206	CbGeAlD
Liotrix—SLCO4C1—vagina—urinary bladder cancer	0.00206	0.0195	CbGeAlD
Liotrix—TTR—renal system—urinary bladder cancer	0.00203	0.0191	CbGeAlD
Liotrix—SLCO1B3—vagina—urinary bladder cancer	0.002	0.0189	CbGeAlD
Liotrix—THRB—vagina—urinary bladder cancer	0.00197	0.0187	CbGeAlD
Liotrix—SLC10A1—female reproductive system—urinary bladder cancer	0.00193	0.0182	CbGeAlD
Liotrix—SLC22A8—prostate gland—urinary bladder cancer	0.00182	0.0172	CbGeAlD
Liotrix—SLCO4A1—renal system—urinary bladder cancer	0.00182	0.0172	CbGeAlD
Liotrix—SLC16A2—vagina—urinary bladder cancer	0.00179	0.0169	CbGeAlD
Liotrix—SLCO4A1—urethra—urinary bladder cancer	0.00178	0.0169	CbGeAlD
Liotrix—SLC16A10—epithelium—urinary bladder cancer	0.00172	0.0162	CbGeAlD
Liotrix—TTR—female reproductive system—urinary bladder cancer	0.00162	0.0153	CbGeAlD
Liotrix—SLCO1B1—renal system—urinary bladder cancer	0.0016	0.0151	CbGeAlD
Liotrix—SLCO4A1—female reproductive system—urinary bladder cancer	0.00145	0.0137	CbGeAlD
Liotrix—SLCO4A1—vagina—urinary bladder cancer	0.00132	0.0124	CbGeAlD
Liotrix—SLCO1A2—renal system—urinary bladder cancer	0.0013	0.0123	CbGeAlD
Liotrix—SLCO1B1—female reproductive system—urinary bladder cancer	0.00128	0.0121	CbGeAlD
Liotrix—THRB—lymph node—urinary bladder cancer	0.00128	0.0121	CbGeAlD
Liotrix—THRA—lymph node—urinary bladder cancer	0.00128	0.0121	CbGeAlD
Liotrix—SLC16A10—female reproductive system—urinary bladder cancer	0.00128	0.012	CbGeAlD
Liotrix—SLC22A8—renal system—urinary bladder cancer	0.00124	0.0117	CbGeAlD
Liotrix—SLC16A2—lymph node—urinary bladder cancer	0.00116	0.0109	CbGeAlD
Liotrix—SLC16A10—vagina—urinary bladder cancer	0.00115	0.0109	CbGeAlD
Liotrix—SLCO1C1—lymph node—urinary bladder cancer	0.00106	0.01	CbGeAlD
Liotrix—CYP2C8—renal system—urinary bladder cancer	0.000909	0.00858	CbGeAlD
Liotrix—SLCO4A1—lymph node—urinary bladder cancer	0.000851	0.00804	CbGeAlD
Liotrix—SLC16A10—lymph node—urinary bladder cancer	0.000746	0.00705	CbGeAlD
Liotrix—CYP2C8—female reproductive system—urinary bladder cancer	0.000728	0.00687	CbGeAlD
Liotrix—CYP2C8—vagina—urinary bladder cancer	0.000658	0.00622	CbGeAlD
Liotrix—ABCB1—prostate gland—urinary bladder cancer	0.000639	0.00604	CbGeAlD
Liotrix—ALB—lymph node—urinary bladder cancer	0.000606	0.00572	CbGeAlD
Liotrix—ABCB1—seminal vesicle—urinary bladder cancer	0.000541	0.00511	CbGeAlD
Liotrix—ABCB1—epithelium—urinary bladder cancer	0.00047	0.00444	CbGeAlD
Liotrix—ABCB1—renal system—urinary bladder cancer	0.000436	0.00412	CbGeAlD
Liotrix—ABCB1—urethra—urinary bladder cancer	0.000428	0.00404	CbGeAlD
Liotrix—ABCB1—female reproductive system—urinary bladder cancer	0.000349	0.0033	CbGeAlD
Liotrix—ABCB1—vagina—urinary bladder cancer	0.000316	0.00298	CbGeAlD
Liotrix—Hypotension—Fluorouracil—urinary bladder cancer	0.000246	0.00121	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000244	0.0012	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000244	0.0012	CcSEcCtD
Liotrix—Tachycardia—Cisplatin—urinary bladder cancer	0.000244	0.0012	CcSEcCtD
Liotrix—Convulsion—Etoposide—urinary bladder cancer	0.000243	0.00119	CcSEcCtD
Liotrix—Dehydration—Epirubicin—urinary bladder cancer	0.000243	0.00119	CcSEcCtD
Liotrix—Insomnia—Gemcitabine—urinary bladder cancer	0.000242	0.00119	CcSEcCtD
Liotrix—Hypertension—Etoposide—urinary bladder cancer	0.000242	0.00119	CcSEcCtD
Liotrix—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000241	0.00118	CcSEcCtD
Liotrix—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000241	0.00118	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00024	0.00118	CcSEcCtD
Liotrix—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000239	0.00117	CcSEcCtD
Liotrix—Chest pain—Etoposide—urinary bladder cancer	0.000239	0.00117	CcSEcCtD
Liotrix—Insomnia—Fluorouracil—urinary bladder cancer	0.000238	0.00117	CcSEcCtD
Liotrix—Anorexia—Cisplatin—urinary bladder cancer	0.000238	0.00117	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—urinary bladder cancer	0.000238	0.00117	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000237	0.00116	CcSEcCtD
Liotrix—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000236	0.00116	CcSEcCtD
Liotrix—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000235	0.00115	CcSEcCtD
Liotrix—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000235	0.00115	CcSEcCtD
Liotrix—Hypotension—Cisplatin—urinary bladder cancer	0.000233	0.00114	CcSEcCtD
Liotrix—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000233	0.00114	CcSEcCtD
Liotrix—Fatigue—Gemcitabine—urinary bladder cancer	0.000231	0.00113	CcSEcCtD
Liotrix—Confusional state—Etoposide—urinary bladder cancer	0.000231	0.00113	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—urinary bladder cancer	0.00023	0.00113	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00023	0.00113	CcSEcCtD
Liotrix—Constipation—Gemcitabine—urinary bladder cancer	0.000229	0.00112	CcSEcCtD
Liotrix—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000229	0.00112	CcSEcCtD
Liotrix—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000229	0.00112	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—urinary bladder cancer	0.000229	0.00112	CcSEcCtD
Liotrix—Asthenia—Thiotepa—urinary bladder cancer	0.000228	0.00112	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000227	0.00112	CcSEcCtD
Liotrix—Infection—Etoposide—urinary bladder cancer	0.000227	0.00111	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—urinary bladder cancer	0.000227	0.00111	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000226	0.00111	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—urinary bladder cancer	0.000225	0.00111	CcSEcCtD
Liotrix—Pruritus—Thiotepa—urinary bladder cancer	0.000225	0.00111	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—urinary bladder cancer	0.000224	0.0011	CcSEcCtD
Liotrix—Paraesthesia—Cisplatin—urinary bladder cancer	0.000224	0.0011	CcSEcCtD
Liotrix—Tachycardia—Etoposide—urinary bladder cancer	0.000223	0.0011	CcSEcCtD
Liotrix—Dyspnoea—Cisplatin—urinary bladder cancer	0.000223	0.00109	CcSEcCtD
Liotrix—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000221	0.00108	CcSEcCtD
Liotrix—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000221	0.00108	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00022	0.00108	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—urinary bladder cancer	0.00022	0.00108	CcSEcCtD
Liotrix—Anorexia—Etoposide—urinary bladder cancer	0.000218	0.00107	CcSEcCtD
Liotrix—Diarrhoea—Thiotepa—urinary bladder cancer	0.000218	0.00107	CcSEcCtD
Liotrix—Decreased appetite—Cisplatin—urinary bladder cancer	0.000217	0.00106	CcSEcCtD
Liotrix—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000217	0.00106	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—urinary bladder cancer	0.000217	0.00106	CcSEcCtD
Liotrix—Hypotension—Etoposide—urinary bladder cancer	0.000214	0.00105	CcSEcCtD
Liotrix—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000213	0.00104	CcSEcCtD
Liotrix—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000212	0.00104	CcSEcCtD
Liotrix—Renal failure—Methotrexate—urinary bladder cancer	0.000211	0.00104	CcSEcCtD
Liotrix—Dizziness—Thiotepa—urinary bladder cancer	0.000211	0.00103	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00021	0.00103	CcSEcCtD
Liotrix—Urticaria—Fluorouracil—urinary bladder cancer	0.000209	0.00103	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—urinary bladder cancer	0.000209	0.00102	CcSEcCtD
Liotrix—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000208	0.00102	CcSEcCtD
Liotrix—Sweating—Methotrexate—urinary bladder cancer	0.000206	0.00101	CcSEcCtD
Liotrix—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000206	0.00101	CcSEcCtD
Liotrix—Paraesthesia—Etoposide—urinary bladder cancer	0.000205	0.00101	CcSEcCtD
Liotrix—ABCB1—lymph node—urinary bladder cancer	0.000204	0.00193	CbGeAlD
Liotrix—Weight decreased—Epirubicin—urinary bladder cancer	0.000204	0.001	CcSEcCtD
Liotrix—Dyspnoea—Etoposide—urinary bladder cancer	0.000204	0.001	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000203	0.000997	CcSEcCtD
Liotrix—Vomiting—Thiotepa—urinary bladder cancer	0.000202	0.000993	CcSEcCtD
Liotrix—Rash—Thiotepa—urinary bladder cancer	0.000201	0.000985	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—urinary bladder cancer	0.000201	0.000984	CcSEcCtD
Liotrix—Dermatitis—Thiotepa—urinary bladder cancer	0.000201	0.000984	CcSEcCtD
Liotrix—Headache—Thiotepa—urinary bladder cancer	0.000199	0.000978	CcSEcCtD
Liotrix—Decreased appetite—Etoposide—urinary bladder cancer	0.000199	0.000975	CcSEcCtD
Liotrix—Renal failure—Epirubicin—urinary bladder cancer	0.000198	0.000969	CcSEcCtD
Liotrix—Body temperature increased—Cisplatin—urinary bladder cancer	0.000197	0.000968	CcSEcCtD
Liotrix—Fatigue—Etoposide—urinary bladder cancer	0.000197	0.000967	CcSEcCtD
Liotrix—Constipation—Etoposide—urinary bladder cancer	0.000196	0.000959	CcSEcCtD
Liotrix—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000194	0.000952	CcSEcCtD
Liotrix—Sweating—Epirubicin—urinary bladder cancer	0.000193	0.000945	CcSEcCtD
Liotrix—Asthenia—Gemcitabine—urinary bladder cancer	0.000192	0.000943	CcSEcCtD
Liotrix—Pruritus—Gemcitabine—urinary bladder cancer	0.00019	0.00093	CcSEcCtD
Liotrix—Nausea—Thiotepa—urinary bladder cancer	0.000189	0.000928	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—urinary bladder cancer	0.000189	0.000926	CcSEcCtD
Liotrix—Feeling abnormal—Etoposide—urinary bladder cancer	0.000188	0.000925	CcSEcCtD
Liotrix—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000187	0.000917	CcSEcCtD
Liotrix—Pruritus—Fluorouracil—urinary bladder cancer	0.000186	0.000914	CcSEcCtD
Liotrix—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000184	0.000902	CcSEcCtD
Liotrix—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000183	0.000899	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—urinary bladder cancer	0.000183	0.000897	CcSEcCtD
Liotrix—Urticaria—Etoposide—urinary bladder cancer	0.000182	0.000891	CcSEcCtD
Liotrix—Abdominal pain—Etoposide—urinary bladder cancer	0.000181	0.000887	CcSEcCtD
Liotrix—Body temperature increased—Etoposide—urinary bladder cancer	0.000181	0.000887	CcSEcCtD
Liotrix—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00018	0.000884	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00018	0.000881	CcSEcCtD
Liotrix—Asthenia—Cisplatin—urinary bladder cancer	0.000179	0.000879	CcSEcCtD
Liotrix—Sweating—Doxorubicin—urinary bladder cancer	0.000178	0.000875	CcSEcCtD
Liotrix—Dizziness—Fluorouracil—urinary bladder cancer	0.000174	0.000854	CcSEcCtD
Liotrix—Diarrhoea—Cisplatin—urinary bladder cancer	0.000171	0.000838	CcSEcCtD
Liotrix—Alopecia—Methotrexate—urinary bladder cancer	0.00017	0.000836	CcSEcCtD
Liotrix—Vomiting—Gemcitabine—urinary bladder cancer	0.00017	0.000835	CcSEcCtD
Liotrix—Rash—Gemcitabine—urinary bladder cancer	0.000169	0.000828	CcSEcCtD
Liotrix—Dermatitis—Gemcitabine—urinary bladder cancer	0.000169	0.000828	CcSEcCtD
Liotrix—Hypersensitivity—Etoposide—urinary bladder cancer	0.000169	0.000827	CcSEcCtD
Liotrix—Headache—Gemcitabine—urinary bladder cancer	0.000168	0.000823	CcSEcCtD
Liotrix—Flushing—Epirubicin—urinary bladder cancer	0.000167	0.000822	CcSEcCtD
Liotrix—Vomiting—Fluorouracil—urinary bladder cancer	0.000167	0.000821	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000166	0.000815	CcSEcCtD
Liotrix—Rash—Fluorouracil—urinary bladder cancer	0.000166	0.000815	CcSEcCtD
Liotrix—Dermatitis—Fluorouracil—urinary bladder cancer	0.000166	0.000814	CcSEcCtD
Liotrix—Headache—Fluorouracil—urinary bladder cancer	0.000165	0.000809	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—urinary bladder cancer	0.000164	0.000806	CcSEcCtD
Liotrix—Asthenia—Etoposide—urinary bladder cancer	0.000164	0.000805	CcSEcCtD
Liotrix—Pruritus—Etoposide—urinary bladder cancer	0.000162	0.000794	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—urinary bladder cancer	0.000161	0.000791	CcSEcCtD
Liotrix—Alopecia—Epirubicin—urinary bladder cancer	0.000159	0.000782	CcSEcCtD
Liotrix—Nausea—Gemcitabine—urinary bladder cancer	0.000159	0.00078	CcSEcCtD
Liotrix—Vomiting—Cisplatin—urinary bladder cancer	0.000159	0.000779	CcSEcCtD
Liotrix—Vision blurred—Methotrexate—urinary bladder cancer	0.000158	0.000776	CcSEcCtD
Liotrix—Rash—Cisplatin—urinary bladder cancer	0.000157	0.000772	CcSEcCtD
Liotrix—Dermatitis—Cisplatin—urinary bladder cancer	0.000157	0.000771	CcSEcCtD
Liotrix—Diarrhoea—Etoposide—urinary bladder cancer	0.000156	0.000768	CcSEcCtD
Liotrix—Nausea—Fluorouracil—urinary bladder cancer	0.000156	0.000767	CcSEcCtD
Liotrix—Flushing—Doxorubicin—urinary bladder cancer	0.000155	0.00076	CcSEcCtD
Liotrix—Flatulence—Epirubicin—urinary bladder cancer	0.000155	0.000759	CcSEcCtD
Liotrix—Tension—Epirubicin—urinary bladder cancer	0.000154	0.000756	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—urinary bladder cancer	0.000154	0.000755	CcSEcCtD
Liotrix—Nervousness—Epirubicin—urinary bladder cancer	0.000153	0.000748	CcSEcCtD
Liotrix—Dizziness—Etoposide—urinary bladder cancer	0.000151	0.000742	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000149	0.000732	CcSEcCtD
Liotrix—Nausea—Cisplatin—urinary bladder cancer	0.000148	0.000727	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—urinary bladder cancer	0.000148	0.000726	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—urinary bladder cancer	0.000148	0.000724	CcSEcCtD
Liotrix—Convulsion—Methotrexate—urinary bladder cancer	0.000145	0.000713	CcSEcCtD
Liotrix—Vomiting—Etoposide—urinary bladder cancer	0.000145	0.000713	CcSEcCtD
Liotrix—Agitation—Epirubicin—urinary bladder cancer	0.000144	0.000708	CcSEcCtD
Liotrix—Rash—Etoposide—urinary bladder cancer	0.000144	0.000707	CcSEcCtD
Liotrix—Dermatitis—Etoposide—urinary bladder cancer	0.000144	0.000707	CcSEcCtD
Liotrix—Headache—Etoposide—urinary bladder cancer	0.000143	0.000703	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—urinary bladder cancer	0.000143	0.000703	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—urinary bladder cancer	0.000143	0.000701	CcSEcCtD
Liotrix—Chest pain—Methotrexate—urinary bladder cancer	0.000143	0.000701	CcSEcCtD
Liotrix—Tension—Doxorubicin—urinary bladder cancer	0.000143	0.0007	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000142	0.000698	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—urinary bladder cancer	0.000141	0.000693	CcSEcCtD
Liotrix—Syncope—Epirubicin—urinary bladder cancer	0.000141	0.000691	CcSEcCtD
Liotrix—Palpitations—Epirubicin—urinary bladder cancer	0.000139	0.000681	CcSEcCtD
Liotrix—Confusional state—Methotrexate—urinary bladder cancer	0.000138	0.000678	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000138	0.000677	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000137	0.000672	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—urinary bladder cancer	0.000137	0.000672	CcSEcCtD
Liotrix—Convulsion—Epirubicin—urinary bladder cancer	0.000136	0.000668	CcSEcCtD
Liotrix—Infection—Methotrexate—urinary bladder cancer	0.000136	0.000668	CcSEcCtD
Liotrix—Nausea—Etoposide—urinary bladder cancer	0.000136	0.000666	CcSEcCtD
Liotrix—Hypertension—Epirubicin—urinary bladder cancer	0.000136	0.000665	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—urinary bladder cancer	0.000134	0.000656	CcSEcCtD
Liotrix—Chest pain—Epirubicin—urinary bladder cancer	0.000134	0.000656	CcSEcCtD
Liotrix—Agitation—Doxorubicin—urinary bladder cancer	0.000134	0.000655	CcSEcCtD
Liotrix—Anxiety—Epirubicin—urinary bladder cancer	0.000133	0.000654	CcSEcCtD
Liotrix—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000132	0.00065	CcSEcCtD
Liotrix—Anorexia—Methotrexate—urinary bladder cancer	0.000131	0.000641	CcSEcCtD
Liotrix—Syncope—Doxorubicin—urinary bladder cancer	0.00013	0.000639	CcSEcCtD
Liotrix—Confusional state—Epirubicin—urinary bladder cancer	0.000129	0.000634	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—urinary bladder cancer	0.000128	0.00063	CcSEcCtD
Liotrix—Oedema—Epirubicin—urinary bladder cancer	0.000128	0.000629	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000128	0.000629	CcSEcCtD
Liotrix—Hypotension—Methotrexate—urinary bladder cancer	0.000128	0.000628	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000128	0.000627	CcSEcCtD
Liotrix—Infection—Epirubicin—urinary bladder cancer	0.000127	0.000625	CcSEcCtD
Liotrix—Shock—Epirubicin—urinary bladder cancer	0.000126	0.000619	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—urinary bladder cancer	0.000126	0.000618	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—urinary bladder cancer	0.000125	0.000616	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—urinary bladder cancer	0.000125	0.000614	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000125	0.000612	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000124	0.000608	CcSEcCtD
Liotrix—Insomnia—Methotrexate—urinary bladder cancer	0.000124	0.000608	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—urinary bladder cancer	0.000124	0.000607	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—urinary bladder cancer	0.000124	0.000607	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—urinary bladder cancer	0.000123	0.000605	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—urinary bladder cancer	0.000123	0.000603	CcSEcCtD
Liotrix—Anorexia—Epirubicin—urinary bladder cancer	0.000122	0.000599	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—urinary bladder cancer	0.000122	0.000599	CcSEcCtD
Liotrix—Hypotension—Epirubicin—urinary bladder cancer	0.00012	0.000588	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—urinary bladder cancer	0.00012	0.000587	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—urinary bladder cancer	0.000119	0.000584	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000119	0.000582	CcSEcCtD
Liotrix—Oedema—Doxorubicin—urinary bladder cancer	0.000119	0.000582	CcSEcCtD
Liotrix—Fatigue—Methotrexate—urinary bladder cancer	0.000118	0.000579	CcSEcCtD
Liotrix—Infection—Doxorubicin—urinary bladder cancer	0.000118	0.000578	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000117	0.000573	CcSEcCtD
Liotrix—Shock—Doxorubicin—urinary bladder cancer	0.000117	0.000573	CcSEcCtD
Liotrix—Insomnia—Epirubicin—urinary bladder cancer	0.000116	0.000569	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—urinary bladder cancer	0.000116	0.000568	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—urinary bladder cancer	0.000115	0.000565	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000115	0.000563	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—urinary bladder cancer	0.000114	0.000561	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—urinary bladder cancer	0.000113	0.000555	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000113	0.000554	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000112	0.00055	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—urinary bladder cancer	0.000111	0.000547	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—urinary bladder cancer	0.000111	0.000544	CcSEcCtD
Liotrix—Fatigue—Epirubicin—urinary bladder cancer	0.000111	0.000542	CcSEcCtD
Liotrix—Constipation—Epirubicin—urinary bladder cancer	0.00011	0.000538	CcSEcCtD
Liotrix—Urticaria—Methotrexate—urinary bladder cancer	0.000109	0.000534	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—urinary bladder cancer	0.000108	0.000531	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—urinary bladder cancer	0.000108	0.000531	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000108	0.00053	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—urinary bladder cancer	0.000107	0.000526	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000107	0.000523	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000106	0.000519	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000106	0.000518	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000105	0.000514	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000103	0.000506	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—urinary bladder cancer	0.000102	0.000502	CcSEcCtD
Liotrix—Urticaria—Epirubicin—urinary bladder cancer	0.000102	0.0005	CcSEcCtD
Liotrix—Constipation—Doxorubicin—urinary bladder cancer	0.000101	0.000498	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—urinary bladder cancer	0.000101	0.000497	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—urinary bladder cancer	0.000101	0.000497	CcSEcCtD
Liotrix—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000101	0.000495	CcSEcCtD
Liotrix—Asthenia—Methotrexate—urinary bladder cancer	9.83e-05	0.000482	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.78e-05	0.00048	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.7e-05	0.000476	CcSEcCtD
Liotrix—Pruritus—Methotrexate—urinary bladder cancer	9.69e-05	0.000475	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—urinary bladder cancer	9.45e-05	0.000463	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—urinary bladder cancer	9.42e-05	0.000462	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—urinary bladder cancer	9.38e-05	0.00046	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—urinary bladder cancer	9.38e-05	0.00046	CcSEcCtD
Liotrix—Diarrhoea—Methotrexate—urinary bladder cancer	9.37e-05	0.00046	CcSEcCtD
Liotrix—Asthenia—Epirubicin—urinary bladder cancer	9.2e-05	0.000451	CcSEcCtD
Liotrix—Pruritus—Epirubicin—urinary bladder cancer	9.07e-05	0.000445	CcSEcCtD
Liotrix—Dizziness—Methotrexate—urinary bladder cancer	9.06e-05	0.000444	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—urinary bladder cancer	8.77e-05	0.00043	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.74e-05	0.000429	CcSEcCtD
Liotrix—Vomiting—Methotrexate—urinary bladder cancer	8.71e-05	0.000427	CcSEcCtD
Liotrix—Rash—Methotrexate—urinary bladder cancer	8.64e-05	0.000424	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—urinary bladder cancer	8.63e-05	0.000423	CcSEcCtD
Liotrix—Headache—Methotrexate—urinary bladder cancer	8.58e-05	0.000421	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—urinary bladder cancer	8.51e-05	0.000418	CcSEcCtD
Liotrix—Dizziness—Epirubicin—urinary bladder cancer	8.48e-05	0.000416	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—urinary bladder cancer	8.39e-05	0.000412	CcSEcCtD
Liotrix—Vomiting—Epirubicin—urinary bladder cancer	8.15e-05	0.0004	CcSEcCtD
Liotrix—Nausea—Methotrexate—urinary bladder cancer	8.14e-05	0.000399	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—urinary bladder cancer	8.12e-05	0.000398	CcSEcCtD
Liotrix—Rash—Epirubicin—urinary bladder cancer	8.08e-05	0.000397	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—urinary bladder cancer	8.08e-05	0.000396	CcSEcCtD
Liotrix—Headache—Epirubicin—urinary bladder cancer	8.03e-05	0.000394	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—urinary bladder cancer	7.84e-05	0.000385	CcSEcCtD
Liotrix—Nausea—Epirubicin—urinary bladder cancer	7.62e-05	0.000374	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—urinary bladder cancer	7.54e-05	0.00037	CcSEcCtD
Liotrix—Rash—Doxorubicin—urinary bladder cancer	7.48e-05	0.000367	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—urinary bladder cancer	7.47e-05	0.000367	CcSEcCtD
Liotrix—Headache—Doxorubicin—urinary bladder cancer	7.43e-05	0.000365	CcSEcCtD
Liotrix—Nausea—Doxorubicin—urinary bladder cancer	7.05e-05	0.000346	CcSEcCtD
Liotrix—SLC10A1—Metabolism—GSTM1—urinary bladder cancer	3.8e-05	0.000615	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	3.79e-05	0.000612	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTT1—urinary bladder cancer	3.74e-05	0.000604	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.72e-05	0.000602	CbGpPWpGaD
Liotrix—TTR—Disease—FGFR3—urinary bladder cancer	3.71e-05	0.0006	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.68e-05	0.000595	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GPX1—urinary bladder cancer	3.64e-05	0.000589	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.59e-05	0.000581	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	3.58e-05	0.000579	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	3.58e-05	0.000579	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—S100B—urinary bladder cancer	3.58e-05	0.000578	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ERCC2—urinary bladder cancer	3.57e-05	0.000578	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTZ1—urinary bladder cancer	3.56e-05	0.000576	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.5e-05	0.000566	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.48e-05	0.000562	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.44e-05	0.000556	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.41e-05	0.000552	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.4e-05	0.000549	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	3.4e-05	0.000549	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NAT1—urinary bladder cancer	3.4e-05	0.000549	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.38e-05	0.000547	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTO2—urinary bladder cancer	3.38e-05	0.000546	CbGpPWpGaD
Liotrix—ALB—Metabolism—NAT1—urinary bladder cancer	3.38e-05	0.000546	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—MTHFR—urinary bladder cancer	3.36e-05	0.000543	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.34e-05	0.00054	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.32e-05	0.000537	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.32e-05	0.000537	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	3.27e-05	0.000529	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	3.24e-05	0.000524	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NCOR1—urinary bladder cancer	3.21e-05	0.00052	CbGpPWpGaD
Liotrix—TTR—Disease—CREBBP—urinary bladder cancer	3.16e-05	0.000511	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.12e-05	0.000505	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	3.11e-05	0.000502	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	3.11e-05	0.000502	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.1e-05	0.000501	CbGpPWpGaD
Liotrix—ALB—Metabolism—UGT2B7—urinary bladder cancer	3.09e-05	0.0005	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.03e-05	0.00049	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.03e-05	0.00049	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.01e-05	0.000487	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.01e-05	0.000487	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.97e-05	0.000481	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.96e-05	0.000479	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.96e-05	0.000479	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.96e-05	0.000479	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	2.94e-05	0.000475	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.93e-05	0.000473	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.89e-05	0.000468	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.87e-05	0.000464	CbGpPWpGaD
Liotrix—TTR—Disease—RHOA—urinary bladder cancer	2.86e-05	0.000462	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MYC—urinary bladder cancer	2.84e-05	0.000459	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MYC—urinary bladder cancer	2.84e-05	0.000459	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TERT—urinary bladder cancer	2.83e-05	0.000458	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	2.8e-05	0.000452	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	2.8e-05	0.000452	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.78e-05	0.00045	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.75e-05	0.000445	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PPARG—urinary bladder cancer	2.72e-05	0.000441	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.72e-05	0.00044	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.71e-05	0.000438	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.65e-05	0.000429	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB2—urinary bladder cancer	2.65e-05	0.000428	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	2.64e-05	0.000427	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.63e-05	0.000425	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.63e-05	0.000425	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CREBBP—urinary bladder cancer	2.62e-05	0.000423	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGFR3—urinary bladder cancer	2.6e-05	0.00042	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	2.59e-05	0.000419	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	2.59e-05	0.000419	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	2.59e-05	0.000419	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—urinary bladder cancer	2.59e-05	0.000419	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	2.57e-05	0.000416	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.57e-05	0.000416	CbGpPWpGaD
Liotrix—ALB—Metabolism—PRSS3—urinary bladder cancer	2.56e-05	0.000414	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ESR1—urinary bladder cancer	2.53e-05	0.000408	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.52e-05	0.000407	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	2.51e-05	0.000406	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.51e-05	0.000405	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.48e-05	0.000401	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.47e-05	0.0004	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	2.44e-05	0.000395	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.44e-05	0.000394	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.43e-05	0.000393	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	2.41e-05	0.000389	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	2.38e-05	0.000385	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	2.38e-05	0.000385	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.37e-05	0.000383	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.35e-05	0.00038	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.3e-05	0.000372	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.28e-05	0.00037	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	2.28e-05	0.000369	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1A—urinary bladder cancer	2.26e-05	0.000366	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—urinary bladder cancer	2.26e-05	0.000365	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.24e-05	0.000363	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	2.24e-05	0.000362	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CREBBP—urinary bladder cancer	2.21e-05	0.000358	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.19e-05	0.000355	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IGF1—urinary bladder cancer	2.19e-05	0.000353	CbGpPWpGaD
Liotrix—TTR—Disease—EP300—urinary bladder cancer	2.15e-05	0.000348	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	2.14e-05	0.000347	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.12e-05	0.000343	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.12e-05	0.000342	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	2.1e-05	0.00034	CbGpPWpGaD
Liotrix—TTR—Disease—SRC—urinary bladder cancer	2.09e-05	0.000339	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000337	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.06e-05	0.000334	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.06e-05	0.000334	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMP—urinary bladder cancer	2.06e-05	0.000333	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.05e-05	0.000332	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMP—urinary bladder cancer	2.05e-05	0.000331	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.04e-05	0.000329	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.02e-05	0.000327	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.02e-05	0.000326	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RHOA—urinary bladder cancer	2e-05	0.000324	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.99e-05	0.000322	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.98e-05	0.00032	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.97e-05	0.000318	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.97e-05	0.000318	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.96e-05	0.000317	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.89e-05	0.000306	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAU—urinary bladder cancer	1.88e-05	0.000304	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—urinary bladder cancer	1.88e-05	0.000303	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.87e-05	0.000302	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.87e-05	0.000302	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—urinary bladder cancer	1.87e-05	0.000302	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.86e-05	0.000301	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—urinary bladder cancer	1.85e-05	0.0003	CbGpPWpGaD
Liotrix—ALB—Metabolism—NAT2—urinary bladder cancer	1.85e-05	0.000299	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—urinary bladder cancer	1.83e-05	0.000297	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.79e-05	0.00029	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.79e-05	0.00029	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—EP300—urinary bladder cancer	1.78e-05	0.000288	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.77e-05	0.000286	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.76e-05	0.000285	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.76e-05	0.000284	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—urinary bladder cancer	1.76e-05	0.000284	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	0.000281	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—urinary bladder cancer	1.73e-05	0.00028	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.72e-05	0.000278	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	1.71e-05	0.000276	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.68e-05	0.000272	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—urinary bladder cancer	1.68e-05	0.000272	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.65e-05	0.000267	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	1.64e-05	0.000265	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.64e-05	0.000265	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—urinary bladder cancer	1.64e-05	0.000265	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.63e-05	0.000263	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.62e-05	0.000262	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000262	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.61e-05	0.00026	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	0.000259	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	0.000259	CbGpPWpGaD
Liotrix—ALB—Metabolism—RRM2—urinary bladder cancer	1.6e-05	0.000258	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—urinary bladder cancer	1.59e-05	0.000257	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—urinary bladder cancer	1.58e-05	0.000256	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—urinary bladder cancer	1.58e-05	0.000256	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.55e-05	0.000251	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IGF1—urinary bladder cancer	1.53e-05	0.000248	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.53e-05	0.000248	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—urinary bladder cancer	1.51e-05	0.000244	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	0.000243	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.49e-05	0.000241	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.49e-05	0.000241	CbGpPWpGaD
Liotrix—ALB—Metabolism—ENO2—urinary bladder cancer	1.48e-05	0.000239	CbGpPWpGaD
Liotrix—ALB—Metabolism—HPGDS—urinary bladder cancer	1.48e-05	0.000239	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.48e-05	0.000239	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—urinary bladder cancer	1.47e-05	0.000238	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.47e-05	0.000238	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—urinary bladder cancer	1.47e-05	0.000237	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.44e-05	0.000234	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.44e-05	0.000233	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—urinary bladder cancer	1.43e-05	0.000232	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.42e-05	0.00023	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	0.000229	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.41e-05	0.000228	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RHOA—urinary bladder cancer	1.4e-05	0.000227	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.4e-05	0.000226	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.34e-05	0.000217	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.34e-05	0.000217	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.34e-05	0.000217	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—urinary bladder cancer	1.31e-05	0.000212	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	0.00021	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.3e-05	0.00021	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	0.000208	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—urinary bladder cancer	1.28e-05	0.000208	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	0.000203	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—urinary bladder cancer	1.21e-05	0.000196	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.2e-05	0.000194	CbGpPWpGaD
Liotrix—ALB—Metabolism—NQO1—urinary bladder cancer	1.19e-05	0.000193	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—urinary bladder cancer	1.18e-05	0.00019	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.18e-05	0.00019	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.17e-05	0.000189	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.16e-05	0.000188	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.16e-05	0.000187	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000185	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.12e-05	0.000181	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	0.000178	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—urinary bladder cancer	1.08e-05	0.000174	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—urinary bladder cancer	1.06e-05	0.000171	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.05e-05	0.000171	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.04e-05	0.000169	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—urinary bladder cancer	1.03e-05	0.000167	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—urinary bladder cancer	1.03e-05	0.000166	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.01e-05	0.000164	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.01e-05	0.000163	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1e-05	0.000162	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—urinary bladder cancer	9.94e-06	0.000161	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.68e-06	0.000156	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.62e-06	0.000156	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—urinary bladder cancer	9.3e-06	0.00015	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—urinary bladder cancer	9.25e-06	0.00015	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	9.2e-06	0.000149	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	9.19e-06	0.000149	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	9.19e-06	0.000149	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—urinary bladder cancer	9.14e-06	0.000148	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOR1—urinary bladder cancer	9.14e-06	0.000148	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	9.02e-06	0.000146	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPX1—urinary bladder cancer	8.8e-06	0.000142	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—urinary bladder cancer	8.77e-06	0.000142	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPX1—urinary bladder cancer	8.75e-06	0.000142	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.71e-06	0.000141	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	8.64e-06	0.00014	CbGpPWpGaD
Liotrix—ALB—Metabolism—ERCC2—urinary bladder cancer	8.59e-06	0.000139	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—urinary bladder cancer	8.51e-06	0.000138	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	8.12e-06	0.000131	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—urinary bladder cancer	8.1e-06	0.000131	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—urinary bladder cancer	8.08e-06	0.000131	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—urinary bladder cancer	8.01e-06	0.000129	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOR1—urinary bladder cancer	8.01e-06	0.000129	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	7.86e-06	0.000127	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.67e-06	0.000124	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—urinary bladder cancer	7.56e-06	0.000122	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.53e-06	0.000122	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—urinary bladder cancer	7.5e-06	0.000121	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—urinary bladder cancer	7.23e-06	0.000117	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—urinary bladder cancer	7.08e-06	0.000114	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—urinary bladder cancer	6.59e-06	0.000107	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—urinary bladder cancer	6.55e-06	0.000106	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	6.33e-06	0.000102	CbGpPWpGaD
Liotrix—ALB—Metabolism—CREBBP—urinary bladder cancer	6.29e-06	0.000102	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.74e-06	9.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.51e-06	8.91e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.18e-06	8.38e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—urinary bladder cancer	5.15e-06	8.33e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.52e-06	7.31e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.51e-06	7.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—urinary bladder cancer	4.49e-06	7.27e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.31e-06	6.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—urinary bladder cancer	4.28e-06	6.93e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.94e-06	6.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—urinary bladder cancer	3.75e-06	6.07e-05	CbGpPWpGaD
